Cancer cell

Results: 3981



#Item
61FULL RESEARCH PUBLICATIONS LIST: 2016 Qiu Z, Wilson RS, Liu Y, R Dun A, Saleeb RS, Liu D, Rickman C, Frame M, Duncan RR, Lu WTranslation Microscropy (TRAM) for super-resolution imaging. Scientific Reports 6 Patel

FULL RESEARCH PUBLICATIONS LIST: 2016 Qiu Z, Wilson RS, Liu Y, R Dun A, Saleeb RS, Liu D, Rickman C, Frame M, Duncan RR, Lu WTranslation Microscropy (TRAM) for super-resolution imaging. Scientific Reports 6 Patel

Add to Reading List

Source URL: www.biochem2.com

Language: English - Date: 2016-02-24 05:19:14
62Forschung aus erster Hand Healthy Ageing 02  Le i

Forschung aus erster Hand Healthy Ageing 02 Le i

Add to Reading List

Source URL: www.leibniz-gesundes-altern.de

Language: English - Date: 2016-06-10 04:51:52
63The 7th Barossa Meeting—Cell Signalling in Cancer Biology and Therapy in Barossa Valley, Australia

The 7th Barossa Meeting—Cell Signalling in Cancer Biology and Therapy in Barossa Valley, Australia

Add to Reading List

Source URL: www.centreforcancerbiology.org.au

Language: English - Date: 2016-03-08 23:32:36
64For immediate release May 27, 2016 Statement on the U.S. National Toxicology Program study that reports cell phones cause cancer by the Advisors to the International EMF Scientist Appeal This $25 million study, executed

For immediate release May 27, 2016 Statement on the U.S. National Toxicology Program study that reports cell phones cause cancer by the Advisors to the International EMF Scientist Appeal This $25 million study, executed

Add to Reading List

Source URL: emfscientist.org

- Date: 2016-05-28 04:56:48
    65PRESS RELEASE – IMMUNOCORE LIMITED  Immunocore’s IMCgp100 Starts Phase I Trial for the Treatment of Uveal Melanoma (Oxford, UK, 30 MarchImmunocore, a world-leading biotechnology company developing novel T cell

    PRESS RELEASE – IMMUNOCORE LIMITED Immunocore’s IMCgp100 Starts Phase I Trial for the Treatment of Uveal Melanoma (Oxford, UK, 30 MarchImmunocore, a world-leading biotechnology company developing novel T cell

    Add to Reading List

    Source URL: www.immunocore.com

    Language: English - Date: 2016-03-29 05:35:06
    66SPECIAL SESSIONSpecial Session 31: Mathematical Models of Cancer and Cancer Therapy Yangjin Kim, KonKuk University, Korea

    SPECIAL SESSIONSpecial Session 31: Mathematical Models of Cancer and Cancer Therapy Yangjin Kim, KonKuk University, Korea

    Add to Reading List

    Source URL: www.aimsciences.org

    Language: English - Date: 2012-06-23 07:34:39
    67CME  A Look at the Near Future of Lung Cancer Treatment Dates of certification: May 31, 2016, to May 31, 2017 Medium: Print with online posttest, evaluation, and request for credit

    CME A Look at the Near Future of Lung Cancer Treatment Dates of certification: May 31, 2016, to May 31, 2017 Medium: Print with online posttest, evaluation, and request for credit

    Add to Reading List

    Source URL: gotoper-com.s3.amazonaws.com

    Language: English - Date: 2016-06-03 12:14:22
    68addition, scientists and clinicians have a long-standing interest in translating basic knowledge into clinical application. The elucidation of how stem cells induce regeneration and repair will provide the bases for soun

    addition, scientists and clinicians have a long-standing interest in translating basic knowledge into clinical application. The elucidation of how stem cells induce regeneration and repair will provide the bases for soun

    Add to Reading List

    Source URL: www.sscn.unige.ch

    Language: English - Date: 2014-07-07 03:35:24
    69Microsoft Word - WhiteEileenBiosketch.doc

    Microsoft Word - WhiteEileenBiosketch.doc

    Add to Reading List

    Source URL: www.biochem2.com

    Language: English - Date: 2015-10-13 05:29:02
    70Application Form, free of charge, for Share Warrants Cell Constraint & Cancer SA SA capital of € 181,RCS TarasconHeadquarters : Le Mas L’Hermite, 331 chemin de la Poterie, F13280 Raphèle-les-Arl

    Application Form, free of charge, for Share Warrants Cell Constraint & Cancer SA SA capital of € 181,RCS TarasconHeadquarters : Le Mas L’Hermite, 331 chemin de la Poterie, F13280 Raphèle-les-Arl

    Add to Reading List

    Source URL: www.cellconstraintcancer.com

    Language: English - Date: 2015-07-01 11:55:31